AdjuderaGet started

Awarded

2ª prorroga SUMINISTRO DE RANIBIZUMAB 10MG/ML SOLUCIÓN INYECTABLE CON DESTINO AL SERVICIO DE FARMACIA DEL HOSPITAL CLÍNICO SAN CARLOS DE MADRID

Original language: Spanish

Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
Buyer
HOSPITAL CLINICO SAN CARLOS
Winners
LABORATORIO STADA SL, NOVARTIS FARMACEUTICA, S.A., TEVA PHARMA, S.L
Contract value
€2,682,848
Published
23 Feb 2026
Awarded
27 Dec 2025
Contract start
27 Dec 2025
Contract end
14 Jan 2027estimated
Sector
Medical equipment and pharmaceuticals
Region
Madrid
Source
Original notice on TED (130448-2026)

More awards from this buyer

AwardedBuyerWinnerContract valuePublished
ATOGEPANT (AQUIPTA 60 mg comprimidos 28 comprimidos)HOSPITAL CLINICO SAN CARLOSABBVIE SPAIN, S.L€243,58828 Oct 2026
ATOGEPANT (AQUIPTA 10 mg comprimidos 28 comprimidos)HOSPITAL CLINICO SAN CARLOSABBVIE SPAIN, S.L€12,99128 Oct 2026
FILSPARI 400 MG COMPRIMIDOS 30 comprimidosHOSPITAL CLINICO SAN CARLOSVIFOR PHARMA ESPAÑA S.L.€253,39428 Oct 2026
FILSPARI 200 MG COMPRIMIDOS 30 comprimidosHOSPITAL CLINICO SAN CARLOSVIFOR PHARMA ESPAÑA S.L.€9,70428 Oct 2026
2ª prorroga RINGER LACTADO SOLUCIÓN ESTÉRIL Y APRIRÓGENA EN AGUA PARA INYECCIÓN FRASCO PLÁSTICO SEMIRRÍGIDO O BOLSA PLASTICOHOSPITAL CLINICO SAN CARLOSFRESENIUS KABI ESPAÑA, S.A.€17,39023 Oct 2026
2ª prorroga GLUCOSALINO SOLUCIÓN ESTÉRIL Y APRIRÓGENA EN AGUA PARA INYECCIÓN ADMINISTRACIÓN IV FRASCO PLÁSTICO SEMIRRÍGIDO O BOLSA PLASTICOHOSPITAL CLINICO SAN CARLOSFRESENIUS KABI ESPAÑA, S.A.€4,88023 Oct 2026